pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy
Status: ACTIVE_NOT_RECRUITING
Conditions: Diabetes Mellitus, Type 2
Interventions: BEHAVIORAL: BT-001|OTHER: Control App
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk
Status: COMPLETED
Conditions: Heart Failure|Chronic Kidney Diseases|Diabetes Mellitus, Type 2
Interventions: OTHER: Medically tailored meals
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
Status: RECRUITING
Conditions: Multiple Myeloma
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Bone Marrow Aspiration|PROCEDURE: Bone Marrow Biopsy|PROCEDURE: Chest Radiography|PROCEDURE: Computed Tomography|BIOLOGICAL: Daratumumab|DRUG: Dexamethasone|DRUG: Lenalidomide|PROCEDURE: Low Dose Computed Tomography of the Whole Body|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Positron Emission Tomography|DRUG: Venetoclax|PROCEDURE: X-Ray Imaging|OTHER: Questionnaire Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Grade III Traction-mobilization in End-range Joint Position in Patients With Hip Osteoarthritis
Status: COMPLETED
Conditions: Osteoarthritis, Hip
Interventions: OTHER: Manual caudal traction mobilization in resting position|OTHER: Manual caudal traction mobilization in end range position|OTHER: Selftreatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: ATAC - Endometrial Sub-Protocol
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole (Arimidex)|DRUG: Tamoxifen (Nolvadex)|DRUG: Nolvadex placebo|DRUG: Arimidex placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose:
Clinical trial: Corticosteroids as an Additional Treatment for Mastoiditis In Children
Status: UNKNOWN
Conditions: Mastoiditis; Acute
Interventions: DRUG: Dexamethasone|DRUG: normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
Status: UNKNOWN
Conditions: Type 2 Diabetes|Pre-diabetes|Insulin Resistance|Cardiovascular Risk
Interventions: DRUG: Curcumin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: DRUG: L-Carnitine|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy
Status: TERMINATED
Conditions: Arthritis, Rheumatoid
Interventions: DRUG: Ofatumumab|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Chlorhexidine Against Sodium Hypochlorite as Skin Antiseptics
Status: COMPLETED
Conditions: Infectious Diseases
Interventions: BIOLOGICAL: Bacterial culture of the prepared skin's areas|OTHER: Preparing skin's areas to be tested|BIOLOGICAL: Antiseptic substantivity
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy
Status: COMPLETED
Conditions: Knee Arthroscopy
Interventions: DRUG: Mepivacaine without fentanyl|DRUG: Mepivacaine with Fentanyl
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Characteristics in Parkinson's Disease
Status: COMPLETED
Conditions: Parkinson Disease|Gait Disorders, Neurologic
Interventions: DEVICE: Noninvasive transcutaneous auricular vagus nerve stimulation at 100Hz|DEVICE: Noninvasive transcutaneous auricular vagus nerve stimulation at 25Hz|DEVICE: Noninvasive transcutaneous earlobe stimulation at 25Hz
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Narratives on Demand for Low and High Ventilated Cigarettes and Substitution for Alternative Products
Status: COMPLETED
Conditions: Cigarette Smoking
Interventions: BEHAVIORAL: High-ventilated cigarette alone|BEHAVIORAL: Low-ventilated cigarette alone|BEHAVIORAL: High- and low-ventilated cigarette with high-ventilated cigarettes increasing in price|BEHAVIORAL: Low- and high-ventilated cigarette with high-ventilated cigarettes increasing in price|BEHAVIORAL: Usual, high- and low-ventilated cigarette with usual cigarettes increasing in price.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.
Status: COMPLETED
Conditions: Infertility
Interventions: DRUG: Follicle Stimulating Hormone|DRUG: Follicle Stimulating Hormone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT
Clinical trial: Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes
Status: COMPLETED
Conditions: Burn
Interventions: DRUG: Instilled 1% Lidocaine|OTHER: Placebo (0.9% Normal Saline)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
Status: RECRUITING
Conditions: Ischemic Stroke, Acute|Sleep Disorders, Circadian Rhythm
Interventions: COMBINATION_PRODUCT: Blue light exposure + Melatonin treatment|DRUG: Melatonin treatment|DEVICE: Blue light exposure|COMBINATION_PRODUCT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours
Status: COMPLETED
Conditions: Advanced Cancer|Hepatic Impairment
Interventions: DRUG: AZD2171
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Responsive Web-based Roadmap (InT-mAp) in Infertility Treatment
Status: RECRUITING
Conditions: Infertility, Female|Web|Anxiety|IVF
Interventions: OTHER: On going treatment|OTHER: InT-mAp
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: MOA Study of Ze 339 in Seasonal Allergic Rhinitis
Status: COMPLETED
Conditions: Seasonal Allergic Rhinitis
Interventions: DRUG: Placebo|DRUG: Desloratadin|DRUG: IG-RD-001 / Ze 339
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)
Status: COMPLETED
Conditions: Coronary Angiography|Chest Pain
Interventions: PROCEDURE: Multi-slice computed tomography|PROCEDURE: Rest-stress Nuclear Myocardial Perfusion Imaging|PROCEDURE: Multi-slice Computed Tomography
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
Status: COMPLETED
Conditions: Fontan Procedure|Hypoplastic Left Heart Syndrome|Tricuspid Atresia
Interventions: DIETARY_SUPPLEMENT: Vitamin C|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Cognitive Effects of Nimodipine in Patients With Schizophrenia
Status: COMPLETED
Conditions: Schizophrenia|Schizo Affective Disorder
Interventions: DRUG: Nimodipine|DRUG: Placebo oral capsule
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer
Status: UNKNOWN
Conditions: Breast Cancer
Interventions: DRUG: INT230-6|OTHER: Saline injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Status: COMPLETED
Conditions: Chronic Hepatitis B
Interventions: DRUG: tenofovir disoproxil fumarate 300mg per day|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome
Status: UNKNOWN
Conditions: Hyperandrogenism|Insulin Resistance
Interventions: OTHER: Dietary intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Anatomic Anterior Cruciate Ligament With Short Hamstring Graft Compare With a Standard Hamstring Graft Technique
Status: COMPLETED
Conditions: Anterior Cruciate Ligament Injuries
Interventions: PROCEDURE: Anatomic anterior cruciate ligament with short hamstring graft technique|PROCEDURE: Anatomic anterior cruciate ligament with a standard hamstring graft technique
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
Status: COMPLETED
Conditions: Raynaud's Phenomenon Isolated Primary|Raynaud's Phenomenon (Secondary)|Healthy
Interventions: PROCEDURE: Biopsy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Status: NOT_YET_RECRUITING
Conditions: Gastric Cancer
Interventions: DRUG: RC48 combined with Sintilimab and XELOX
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Stimulate One Hand to Improve Tactile Perception on the Other
Status: RECRUITING
Conditions: Post-stroke Sensory Deficits at the Hand
Interventions: PROCEDURE: Repetitive somatosensory stimulation (RSS)|PROCEDURE: Sham Repetitive somatosensory stimulation (RSS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: The Effect of Portion Sizes on Mood
Status: ACTIVE_NOT_RECRUITING
Conditions: Mood|Eating Patterns
Interventions: OTHER: Control|OTHER: Increase Portion Size|OTHER: Decrease Portion Size|OTHER: Mixed Portions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
Status: COMPLETED
Conditions: Depression
Interventions: DRUG: Ketamine|DRUG: Diphenhydramine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Prevention of Post-Traumatic Stress Disorder in Soldiers
Status: COMPLETED
Conditions: Post-traumatic Stress Disorder (PTSD)|Aggressive Behavior
Interventions: BEHAVIORAL: Preventive Narrative Exposure Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
Status: UNKNOWN
Conditions: Parkinson Disease Psychosis
Interventions: DRUG: Saracatinib|DRUG: Placebo Oral Tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam
Status: RECRUITING
Conditions: Wound
Interventions: DEVICE: ActivHeal Silicone PHMB Foam Adhesive and Non Adhesive dressing.
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2
Status: COMPLETED
Conditions: Influenza (Pandemic)
Interventions: BIOLOGICAL: Monovalent Avian Influenza VLP (H5N1)|BIOLOGICAL: Monovalent Avian Influenza VLP (H5N1)|BIOLOGICAL: Monovalent Avian Influenza VLP (H5N1); Adjuvant|BIOLOGICAL: Monovalent Avian Influenza VLP (H5N1); Adjuvant|BIOLOGICAL: Monovalent Avian Influenza VLP (H5N1); Adjuvant|BIOLOGICAL: Saline Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
Status: TERMINATED
Conditions: Prostate Cancer
Interventions: DRUG: Burixafor Hydrobromide|DRUG: Docetaxel|DRUG: G-CSF
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pulmonary Recruitment Maneuver for Postlaparoscopic Shoulder Pain
Status: COMPLETED
Conditions: Gynecologic Diseases
Interventions: PROCEDURE: 40 cmH2O|PROCEDURE: 60 cmH2O|PROCEDURE: Passive deflation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women
Status: COMPLETED
Conditions: Postmenopause
Interventions: DRUG: Bazedoxifene and conjugated estrogens
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System
Status: COMPLETED
Conditions: Healthy
Interventions: OTHER: EyeGate II® Drug Delivery System|DRUG: Citrate buffer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
Status: WITHDRAWN
Conditions: Bladder Cancer
Interventions: DRUG: Rogaratinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Needle-free Injection System on Dental Injection Pain in Children
Status: COMPLETED
Conditions: Anesthesia, Local|Child Behavior|Pain
Interventions: DEVICE: Injection with the needle-free (NF) system|DEVICE: Injection with the traditional method (TM)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effects of Phototherapy in Preterm Infants Pda
Status: UNKNOWN
Conditions: Patent Ductus Arteriosus After Premature Birth|Hyper Bilirubinemia
Interventions: OTHER: Group 1: non chest shielding|OTHER: Group 2: chest shielding
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF
Status: RECRUITING
Conditions: Atrial Fibrillation|Stroke
Interventions: DRUG: Oral anticoagulant
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Diagnostic Importance of the C-reactive Protein From Blood and Saliva in Children With Acute Appendicitis
Status: NOT_YET_RECRUITING
Conditions: Acute Appendicitis
Interventions: DIAGNOSTIC_TEST: Blood specimen collection for C-reactive protein (CRP) and WBC (white blood cells). Saliva specimen collection for analysis of CRP levels
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Mature B-Cell Lymphoma And Leukemia Study III
Status: ACTIVE_NOT_RECRUITING
Conditions: Mature B-Cell Lymphoma
Interventions: DRUG: COPAD|DRUG: COP, COPD M3, CYM|DRUG: COP, COPADM8, CYVE
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations
Status: COMPLETED
Conditions: Oncology|Taste, Altered
Interventions: DIETARY_SUPPLEMENT: Fortimel/Nutridrink Compact Protein
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
Status: TERMINATED
Conditions: Advanced Non Small Cell Lung Cancer (NSCLC)
Interventions: DRUG: AUY922|DRUG: Docetaxel|DRUG: Pemetrexed
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy
Status: COMPLETED
Conditions: Meniscus Lesion|Pain (Knee)|Diagnostic Knee Artroscopy|Minor Knee Surgery
Interventions: PROCEDURE: Adductor-Canal-Block, Ropivacain|PROCEDURE: Adductor Canal Block, Placebo (saline)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee
Status: COMPLETED
Conditions: Knee Osteoarthritis
Interventions: DRUG: UBX0101|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock
Status: COMPLETED
Conditions: Shock; Septic|Critical Illness
Interventions: OTHER: Hemodynamical treatment TTP|OTHER: Hemodynamical treatment MCG
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
Status: WITHDRAWN
Conditions: Hepatic Encephalopathy
Interventions: DRUG: Rifaximin|DRUG: Lactulose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer
Status: RECRUITING
Conditions: Breast Cancer
Interventions: DRUG: BCD-178|DRUG: Perjeta
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation
Status: WITHDRAWN
Conditions: Atrial Fibrillation
Interventions: DEVICE: Wearing Cardioskin™ for 14 days
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Prostate Cancer Recurrent
Interventions: BIOLOGICAL: RV001V|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DRUG: Temsirolimus|DRUG: Neratinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease
Status: RECRUITING
Conditions: Parkinson Disease
Interventions: OTHER: neuropsychological assessment|OTHER: biological sample|PROCEDURE: medical imagery
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Does Anesthetic Technique Affect Pneumatic Tourniquet Pressures in Upper Limb Fracture Surgery?
Status: COMPLETED
Conditions: Initial Systolic Blood Pressure (mmHg)|Arterial Occlusion Pressure (mmHg)|Tourniquet Time (Minutes)|Quality of Bloodless Surgical Field (4 Point Scale)|Initial Tourniquet Pressure (mmHg)|Maximal Systolic Blood Pressure (mmHg)|Maximal Tourniquet Pressure (mmHg)
Interventions: PROCEDURE: Upper limb fracture surgery and arterial occlusion pressure (AOP) estimation based tourniquet pressure (TP) setting
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers
Status: RECRUITING
Conditions: Tobacco Smoking
Interventions: BEHAVIORAL: Adapt2Quit|BEHAVIORAL: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Status: UNKNOWN
Conditions: Diabetic Macular Edema|Diabetic Retinopathy|Retinal Ischemia
Interventions: DRUG: Ozurdex Drug Implant Product
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Status: UNKNOWN
Conditions: Diabetic Macular Edema
Interventions: DRUG: Infliximab (intravitreal, 2.0mg/0.05ml)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of SmtO2 Guided Care on PONV (iMODIPONV)
Status: COMPLETED
Conditions: Postoperative Nausea and Vomiting|Hysterectomy|Tissue Oxygenation|Cardiac Output Management|Blood Pressure Management
Interventions: DEVICE: Muscular tissue oxygen saturation guided care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study
Status: UNKNOWN
Conditions: Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)
Interventions: DRUG: Lumigan PF; Xalatan
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Status: COMPLETED
Conditions: Congenital Bleeding Disorder|Haemophilia A
Interventions: DRUG: turoctocog alfa|DRUG: turoctocog alfa
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations
Status: COMPLETED
Conditions: Infiltrating Urothelial Carcinoma|KRAS Gene Mutation
Interventions: DRUG: Chemotherapy|DRUG: Panitumumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
Status: TERMINATED
Conditions: Renal Cell Cancer Metastatic
Interventions: DRUG: CT053PTSA
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Status: UNKNOWN
Conditions: Hand, Foot and Mouth Disease
Interventions: OTHER: Western therapy|DRUG: Xiyanping Injection|DRUG: Xiyanping Injection with western medicine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Rehabilitative Game Exercise and Body Awareness Therapy in Rotator Cuff Syndrome
Status: RECRUITING
Conditions: Rotator Cuff Syndrome
Interventions: BEHAVIORAL: Conventional Exercise Group|BEHAVIORAL: Body Awareness Training Group|BEHAVIORAL: Rehabilitative Game Exercise Group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of ZN-c3 in Subjects With High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Interventions: DRUG: ZN-c3
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Patient Satisfaction , Marginal Adaptation And Biocompatibility of Milled Biohpp Polyetheretherketone (PEEK) Single Anterior Crowns Veneered With Two Different Techniques.
Status: COMPLETED
Conditions: Patient Satisfaction|Gingival Bleeding
Interventions: COMBINATION_PRODUCT: peek
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Genomic Approach for Clopidogrel in Caribbean Hispanics
Status: ACTIVE_NOT_RECRUITING
Conditions: Cardiovascular Disease (CVD)|Stroke|Acute Coronary Syndrome|Peripheral Arterial Disease|Coronary Artery Disease|Myocardial Infarction
Interventions: GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 assay
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
Status: COMPLETED
Conditions: Sebum Production|Stool Microbiome|Transepidermal Water Loss|Facial Brrightness|Erythema|Wrinkles|Facial Shine
Interventions: DIETARY_SUPPLEMENT: Placebo Oral Tablet|DIETARY_SUPPLEMENT: Rubia Cordifolia|DIETARY_SUPPLEMENT: Triphala
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency
Status: COMPLETED
Conditions: Idiopathic Growth Hormone Deficiency
Interventions: DRUG: CinnaTropin®|DRUG: Nordilet®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Status: COMPLETED
Conditions: Mesothelioma|Pancreatic Cancer|Ovarian Cancer|Non-small Cell Lung Cancer
Interventions: DRUG: Amatuximab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Adjuncts to IVRA, a Comparison Between Ketorolac and Paracetamol
Status: COMPLETED
Conditions: Postoperative Pain
Interventions: DRUG: Lidocaine|DRUG: Ketorolac|DRUG: paracetamol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being.
Status: UNKNOWN
Conditions: Learning Disorders|Depression|Anxiety
Interventions: OTHER: Exercise|OTHER: Relaxation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness
Status: COMPLETED
Conditions: Vulvar Atrophy
Interventions: DEVICE: Cellular Matrix BCT-HA Kit
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Narrative Exposure Based Intervention For Post-Traumatic Stress Disorder
Status: UNKNOWN
Conditions: Post Traumatic Stress Disorder
Interventions: BEHAVIORAL: Trauma Related Expressive Writing|BEHAVIORAL: Neutral Expressive Writing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of Active Reminders and Motivational Techniques on Oral Hygiene and Gingival Health in Orthodontic Patients
Status: COMPLETED
Conditions: Oral Hygiene|White Spot Lesion|Gingivitis
Interventions: BEHAVIORAL: Oral hygiene instructions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial
Status: UNKNOWN
Conditions: Postoperative Hyperglycemia|Stress Hyperglycemia
Interventions: DRUG: SGLT2 inhibitor|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Traditional Chinese Medicine Intervention for Women With Menopausal Syndrome
Status: COMPLETED
Conditions: Menopausal Syndrome
Interventions: OTHER: TCM intervention|OTHER: Western intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Improving Learning in Hispanics With TBI or MS
Status: UNKNOWN
Conditions: TBI (Traumatic Brain Injury) or MS (Multiple Sclerosis)
Interventions: BEHAVIORAL: Spanish modified Story Memory Technique (mSMT)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pilot Study of the Endolumik Gastric Calibration Tube for Bariatric Surgery
Status: UNKNOWN
Conditions: Morbid Obesity
Interventions: DEVICE: Endolumik Gastric Calibration Tube (EGCT)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)
Status: TERMINATED
Conditions: Lymphocytic Leukemia, Chronic|Lymphoma, Small Lymphocytic
Interventions: DRUG: IPI-145 (duvelisib)|DRUG: Obinutuzumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa
Status: RECRUITING
Conditions: Hidradenitis Suppurativa
Interventions: BIOLOGICAL: Injectable suspension of allogeneic adult mesenchymal stem cells|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Status: TERMINATED
Conditions: Non-infectious Uveitis
Interventions: DRUG: Basiliximab|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
Status: UNKNOWN
Conditions: Diabetic Retinopathy
Interventions: DRUG: ranibizumab and vitrectomy|PROCEDURE: vitrectomy without preoperative ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab
Status: COMPLETED
Conditions: Non-Small Cell Lung Cancer
Interventions: DRUG: AMG 951 (rhApo2L/TRAIL)|DRUG: Bevacizumab|DRUG: Carboplatin|DRUG: Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery
Status: TERMINATED
Conditions: Neuroendocrine Tumors|Neuroendocrine Carcinoma|Neuroendocrine Neoplasms|Carcinoma, Neuroendocrine|Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas
Interventions: DRUG: Sunitinib|DRUG: Everolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
Status: UNKNOWN
Conditions: Lichen Planus
Interventions: DRUG: Apremilast (CC-10004)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Status: COMPLETED
Conditions: Hereditary Thyroid Gland Medullary Carcinoma|Locally Advanced Thyroid Gland Medullary Carcinoma|Multiple Endocrine Neoplasia Type 2A|Multiple Endocrine Neoplasia Type 2B|Recurrent Thyroid Gland Medullary Carcinoma|Sporadic Thyroid Gland Medullary Carcinoma|Stage III Thyroid Gland Medullary Carcinoma AJCC v7|Stage IV Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
Interventions: DRUG: Sorafenib Tosylate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
Status: UNKNOWN
Conditions: Anemia, Aplastic
Interventions: DRUG: Eltrombopag|DRUG: Placebo (for Eltrombopag)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
Status: COMPLETED
Conditions: REM Sleep Behavior Disorder|Parkinson Disease
Interventions: DRUG: Sodium Oxybate|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital
Status: COMPLETED
Conditions: Postpartum Depression|Postpartum Anxiety
Interventions: BEHAVIORAL: ROSE|OTHER: Standard of Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study Of The Selective PKC-β Inhibitor MS- 553
Status: TERMINATED
Conditions: Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Aggressive Lymphoma
Interventions: DRUG: MS-553|DRUG: MS-553|DRUG: acalabrutinib|DRUG: venetoclax|DRUG: Rituximab|DRUG: obinutuzumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy
Status: COMPLETED
Conditions: Anesthesia|ECT
Interventions: DRUG: Etomidate|DRUG: Sevoflurane
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
Status: COMPLETED
Conditions: Anaemia Associated With Chronic Kidney Disease
Interventions: DRUG: efepoetin alfa|DRUG: Mircera
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
Status: RECRUITING
Conditions: Squamous Cell Carcinoma of Head and Neck|Metastatic Squamous Cell Carcinoma
Interventions: BIOLOGICAL: TBio-4101|DRUG: Pembrolizumab|DRUG: Platinum based chemotherapy|DRUG: Cyclophosphamide|DRUG: Fludarabine|DRUG: Aldesleukin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation
Status: UNKNOWN
Conditions: Respiratory Insufficiency
Interventions: DEVICE: NIPPV|DEVICE: NHFOV
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
Status: RECRUITING
Conditions: Head and Neck Squamous Cell Carcinoma|Metastatic Head and Neck Squamous Cell Carcinoma|Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Interventions: BIOLOGICAL: Panitumumab|DRUG: Zirconium Zr 89 Panitumumab|PROCEDURE: Positron Emission Tomography|PROCEDURE: Computed Tomography|OTHER: Electronic Health Record Review
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Clinical Study on Hyaluronic Acid With Lidocaine for the Treatment of Moderate to Severe Nasolabial Folds
Status: UNKNOWN
Conditions: Nasolabial Folds
Interventions: DEVICE: hyaluronic acid plus lidocaine|DEVICE: hyaluronic acid without lidocaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer
Status: COMPLETED
Conditions: Ovarian Cancer
Interventions: DRUG: paclitaxel|DRUG: pazopanib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery
Status: UNKNOWN
Conditions: Wounds
Interventions: DEVICE: PainShield|DEVICE: Sham PainShield
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: MCG for Localization of Tachyarrhythmia's Origin
Status: RECRUITING
Conditions: Tachyarrhythmia|Atrial Flutter|Paroxysmal Supraventricular Tachycardia|Atrial Tachycardia|Atrial Fibrillation|Premature Ventricular Contraction
Interventions: DEVICE: Magnetocardiography
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test formulation, Torrent Pharmaceutical Limited., India)
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose:
Clinical trial: The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability
Status: RECRUITING
Conditions: Shoulder Dislocation
Interventions: PROCEDURE: Anatomic Glenoid Reconstruction|PROCEDURE: Arthroscopic bankart Repair
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Vaginal Packing After Laparoscopic Sacrocolpopexy
Status: ACTIVE_NOT_RECRUITING
Conditions: Vaginal Packing Following Laparoscopic Sacrocolpopexy|Pelvic Organ Prolapse
Interventions: PROCEDURE: vaginal packing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy
Status: RECRUITING
Conditions: Helicobacter Pylori
Interventions: DRUG: Standard bismuth quadruple
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Transcranial Direct/ Alternating Current Stimulation for Parkinson's Disease Treatment
Status: COMPLETED
Conditions: tACS|tDCS
Interventions: DEVICE: tACS|DEVICE: tDCS|DEVICE: sham
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Brain Effects of Escitalopram and Citalopram Using fMRI
Status: COMPLETED
Conditions: Antidepressant Activity in Healthy Volunteers
Interventions: DRUG: Escitalopram|DRUG: Citalopram|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Optical Coherence Tomography in Long Lesions
Status: UNKNOWN
Conditions: Coronary Artery Disease
Interventions: DEVICE: Resolute Sprint|DEVICE: Sirolimus Eluting Stent|DEVICE: Paclitaxel Eluting Stent|DEVICE: Zotarolimus eluting stent
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"
Status: TERMINATED
Conditions: Cerebral Infarction
Interventions: DRUG: Fluoxetine|DRUG: Placebo of fluoxetine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Status: COMPLETED
Conditions: Dengue|Dengue Fever|Dengue Hemorrhagic Fever
Interventions: BIOLOGICAL: CYD Dengue Vaccine|BIOLOGICAL: CYD Dengue Vaccine|BIOLOGICAL: Japanese Encephalitis Vaccine|BIOLOGICAL: Japanese Encephalitis Vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Pilot Study on Training Emerging Adults Skills in Navigating College
Status: COMPLETED
Conditions: Alcohol Abuse|Cognitive Deficit in Attention
Interventions: BEHAVIORAL: Koru Mindfulness (KM) Training|BEHAVIORAL: Navigating College (NC) Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Cultural Arts Programme for Older Chinese
Status: ACTIVE_NOT_RECRUITING
Conditions: Depressive Symptoms|Ageism|Older Adults|Psychosocial Intervention|Art
Interventions: BEHAVIORAL: Cultural Arts Program|BEHAVIORAL: Treatment as usual
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION